Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials
Min Wei,1 Dongmei Duan21Department of Orthopedics, 2Department of Traditional Chinese Medicine, People’s Liberation Army General Hospital, Beijing, People’s Republic of China Abstract: T-helper 17 (Th17) pathway plays an important and distinct role in autoimmunity and inflammatio...
Saved in:
Main Authors: | Wei M (Author), Duan D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
by: Liu L, et al.
Published: (2016) -
NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010) -
NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010) -
The Efficacy and Safety of Monoclonal Antibody Treatments Against COVID-19: A Systematic Review and Meta-analysis of Randomized Clinical Trials
by: Ifan Ali Wafa, et al.
Published: (2023) -
Pachydermoperiostosis complicated with psoriatic arthritis successfully treated with an anti-interleukin 17A antibody
by: Kyoko Sugioka, MD, et al.
Published: (2023)